TBX4 and pancreatic ductal adenocarcinoma: Further research in pancreatic ductal adenocarcinoma has shown that TBX4 expression decreases progressively with declining tumor differentiation, raising the possibility that reduced TBX4 levels may serve as an indicator of increasing tumor aggressiveness.